A1 Refereed original research article in a scientific journal

Novel Hydrazine Molecules as Tools To Understand the Flexibility of Vascular Adhesion Protein-1 Ligand-Binding Site: Toward More Selective Inhibitors




AuthorsNurminen EM, Pihlavisto M, Lazar L, Pentikainen U, Fulop F, Pentikainen OT

PublisherAMER CHEMICAL SOC

Publication year2011

JournalJournal of Medicinal Chemistry

Journal name in sourceJOURNAL OF MEDICINAL CHEMISTRY

Journal acronymJ MED CHEM

Volume54

Issue7

First page 2143

Last page2154

Number of pages12

ISSN0022-2623

DOIhttps://doi.org/10.1021/jm200059p


Abstract
Vascular adhesion protein-1 (VAP-1) belongs to a family of amine oxidases. It plays a role in leukocyte trafficking and in amine compound metabolism. VAP-1 is linked to various diseases, such as Alzheimer's disease, psoriasis, depression, diabetes, and obesity. Accordingly, selective inhibitors of VAP-1 could potentially be used to treat those diseases. In this study, eight novel VAP-1 hydrazine derivatives were synthesized and their VAP-1 and monoamine oxidase (MAO) inhibition ability was determined in vitro. MD simulations of VAP-1 with these new molecules reveal that the VAP-1 ligand-binding pocket is flexible and capable of fitting substantially larger ligands than was previously believed. The increase in the size of the VAP-1 ligands, together with the methylation of the secondary nitrogen atom of the hydrazine moiety, improves the VAP-1 selectivity over MAO.



Last updated on 2024-26-11 at 18:11